Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
366 Leser
Artikel bewerten:
(1)

Join the Leaders in the 8th Annual High Potent Medicines Conference by MarketsandMarkets at Duo Milan Porta Nuova, Italy

MILAN, April 25, 2023 /PRNewswire/ -- MarketsandMarkets, a leading market research organization, is pleased to announce the venue details for its 8th Annual High Potent Medicines Conference. The event will be held in Milan, Italy, from May 24th to May 26th, 2023, at the Duo Milan Porta Nuova, Via Gerolamo Cardano, 1, 20124 Milano MI, Italy.

MarketsandMarkets Logo

The Duo Milan Porta Nuova is a state-of-the-art conference venue that is ideally suited for this year's event. The venue is equipped with the latest technology, and it offers a spacious and comfortable environment for attendees to engage in productive discussions and exchange ideas. We believe that the venue will provide an ideal setting for our attendees to learn, connect, and network.

The conference will bring together leading experts from the pharmaceutical industry to discuss and exchange ideas on the latest developments in the field of high potent medicines. The theme for this year's conference is "Innovations in High Potent Medicines Manufacturing & Development."

The number of new medicines that contain highly potent active pharmaceutical ingredients (HPAPIs) is large and rising. According to estimates, HPAPIs make up more than 25% of all novel medications under development, including antibody-drug conjugates (ADCs). Over the past ten years, numerous pharmaceutical firms, and contract manufacturing organisations (CMOs) have made investments in HPAPI manufacturing facilities. And to learn more about Strategic Elements in HPAPI Projects, attend the specially designed, highly effective conference where the Keynote Speaker, Justin Mason-Home, Director, HPAPI Services, will discuss the topic.

With this, the High Potent Medicines conference will also feature keynote speeches from industry leaders, panel discussions, and presentations on the latest trends and advancements in high potent medicines. The event will provide an excellent opportunity for attendees to network with other professionals in the field and to gain valuable insights into the latest developments in the industry.

This high potent medicines conference will also feature keynote presentations, panel discussions, case studies, and interactive workshops, covering topics such as handling high potent drugs, occupational safety, analytical techniques, and new drug development strategies. The conference will also provide ample opportunities for attendees to connect with leading service providers and suppliers of high potent drug products. Witness an excellent range of sponsors, exhibitors and partner which include:

  • FPS Food and Pharma Systems
  • Dec
  • PCI Pharma Services
  • HOSOKAWA ALPINE
  • BSP
  • Siegfried
  • Moehs Group
  • Aenova Group
  • CTS Europe Ltd
  • Lugaia
  • ANGELINI PHARMA
  • ALMAC
  • MUNIT
  • CSV Containment
  • BEA Technologies
  • I.B.D. International Business Development

The event is expected to attract a diverse group of attendees, including pharmaceutical manufacturers, CMOs, CROs, regulatory agencies, and academic researchers. The conference is an excellent opportunity for attendees to gain valuable insights into the latest trends and advancements in high potent medicines.

Registration for exhibits is now closed.

ONLY 3 SLOTS LEFT for - Speaking Opportunities & One-on-One Meetings.

WHY WAIT - REGISTER TODAY

About MarketsandMarkets

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.events.marketsandmarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Ms. Nayantara Patil
MarketsandMarkets INC.
IND: +91-7030560809
Email: Nayantara.patil@mnmconferences.com

For more information about the 8th Annual High Potent Medicines Conference, visit the conference website or contact Marketing-CNC directly.

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/join-the-leaders-in-the-8th-annual-high-potent-medicines-conference-by-marketsandmarkets-at-duo-milan-porta-nuova-italy-301805423.html

© 2023 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.